August 4, 2015Open Access

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Key Points

Key points are not available for this paper at this time.

Abstract

The R-ISS is a simple and powerful prognostic staging system, and we recommend its use in future clinical studies to stratify patients with NDMM effectively with respect to the relative risk to their survival.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Palumbo et al. (Tue,) studied this question.

synapsesocial.com/papers/69d73ef358d71cbec648f451 https://doi.org/https://doi.org/10.1200/jco.2015.61.2267

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison Of Conventional, FISH and GEP Prognostic Factors In Multiple Myeloma: Introducing a Novel Risk Stratification2013 · 3 citations
2A Phase III Study Of ASCT Vs Cyclophosphamide-Lenalidomide-Dexamethasone and Lenalidomide-Prednisone Maintenance Vs Lenalidomide Alone In Newly Diagnosed Myeloma Patients2013 · 30 citations
3Multiple myeloma2000 · 2,176 citations
4Gay F, Magarotto V, Crippa C, et al. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. Blood. 2013;122(8):1376-1383.2014 · 8 citations
5International Staging System for Multiple Myeloma2005 · 2,919 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper